Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Ranbaxy Laboratories > September 21, 2005

      Ranbaxy may launch anti-malaria drug in 2009

      Posted AtManorma Online

      Pharma giant Ranbaxy Laboratries Ltd said it was likely to launch its anti-malaria drug by 2009 for which the clinical trials were currently going on.

      "We are doing Phase-II clinical trials for a new chemical entity for malaria and if everything goes well we expect the product to hit the market by 2008-09," Malvinder Mohan Singh Ranbaxy President (Pharmaceuticals) said on the sidelines of the CII technology summit.

      The company was conducting clinical trials in three countries at present for the chemical 'synthetic artemesinin'. The drug is likely to be in tablet form. The company added that it would begin its Canadian operations for sales and marketing as part of its strategy to expand in the overseas markets.

      Singh said "we well look at marketing generic products portfolio and drugs which are about to go off-patent." The Canadian operation is a completely sales and marketing oriented and it is part of the company's strategy to expand overseas with Canada being the eight largest pharma market in the world.

      September 21, 2005


      Share this Article!

    Back to top^